In a previous study, we demonstrated that the loss of Ccrl2 in the host accelerates papilloma development in a chemical model of skin carcinogenesis, whereas CCRL2 overexpression in B16 melanoma or LLC cells delays tumor graft growth in vivo [29]. The gene discussed is CCRL2; the disease is melanoma.